Variant report

Variant	rs72932964
Chromosome Location	chr3:50340582-50340583
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:50340246-50341385	K562	blood:	n/a	n/a
2	RAD21	chr3:50340476-50340731	MCF-7	breast:	n/a	chr3:50340622-50340634
3	CTCF	chr3:50340462-50340691	HepG2	liver:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
4	CTCF	chr3:50340440-50340590	HCPEpiC	choroid plexus:	n/a	chr3:50340534-50340542
5	CTCF	chr3:50340175-50341006	SK-N-SH	brain:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
6	CEBPB	chr3:50340347-50340653	HepG2	liver:	n/a	n/a
7	MAZ	chr3:50340389-50341232	HepG2	liver:	n/a	chr3:50341173-50341183
8	MAX	chr3:50340369-50340806	K562	blood:	n/a	n/a
9	CTCF	chr3:50340480-50340630	HPAF	blood vessel:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
10	POLR2A	chr3:50339436-50341410	Hela-S3	cervix:	n/a	n/a
11	POLR2A	chr3:50340195-50341136	HUVEC	blood vessel:	n/a	n/a
12	CTCF	chr3:50340408-50340684	K562	blood:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
13	POLR2A	chr3:50340505-50341433	HCT-116	colon:	n/a	n/a
14	CTCF	chr3:50340455-50340681	A549	lung:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
15	CTCF	chr3:50340551-50340631	ProgFib	skin:	n/a	chr3:50340580-50340598 chr3:50340581-50340597
16	MAX	chr3:50339747-50341427	HepG2	liver:	n/a	chr3:50341173-50341183
17	TAF1	chr3:50340235-50341359	HepG2	liver:	n/a	n/a
18	CTCF	chr3:50340500-50340650	HPF	lung:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
19	CTCF	chr3:50340518-50340662	GM12892	blood:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
20	CTCF	chr3:50340453-50340716	MCF-7	breast:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
21	CTCF	chr3:50340480-50340630	GM12866	blood:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
22	CTCF	chr3:50340520-50340670	HVMF	connective:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
23	CTCF	chr3:50340504-50340642	SK-N-SH_RA	brain:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
24	SP1	chr3:50340275-50341339	HepG2	liver:	n/a	chr3:50341068-50341080 chr3:50341149-50341158 chr3:50341148-50341160 chr3:50341229-50341243 chr3:50341068-50341080 chr3:50341148-50341160 chr3:50341148-50341159 chr3:50341172-50341184 chr3:50341058-50341067 chr3:50341150-50341159 chr3:50341070-50341079 chr3:50341149-50341159 chr3:50341172-50341184 chr3:50341173-50341183 chr3:50341172-50341183 chr3:50340474-50340488 chr3:50341149-50341159 chr3:50341145-50341159
25	RAD21	chr3:50340478-50340620	K562	blood:	n/a	n/a
26	POLR2A	chr3:50340232-50341393	Hela-S3	cervix:	n/a	n/a
27	CTCF	chr3:50340440-50340590	GM12878	blood:	n/a	chr3:50340534-50340542
28	MYC	chr3:50340510-50340645	MCF10A-Er-Src	breast:	n/a	n/a
29	CTCF	chr3:50340532-50340669	IMR90	lung:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
30	POLR2A	chr3:50340171-50341206	HepG2	liver:	n/a	n/a
31	CTCF	chr3:50340480-50340630	HL-60	blood:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
32	CTCF	chr3:50340440-50340590	HEK293	kidney:	n/a	chr3:50340534-50340542
33	TBP	chr3:50340490-50341252	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr3:50340440-50340690	BJ	skin:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
35	BHLHE40	chr3:50340229-50340694	K562	blood:	n/a	n/a
36	MAX	chr3:50340430-50341381	Hela-S3	cervix:	n/a	chr3:50341173-50341183
37	CTCF	chr3:50340560-50340710	HRPEpiC	eye:	n/a	chr3:50340580-50340598 chr3:50340581-50340597
38	CTCF	chr3:50340494-50340691	K562	blood:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
39	YY1	chr3:50340132-50341423	HepG2	liver:	n/a	n/a
40	MYC	chr3:50340259-50341168	HepG2	liver:	n/a	n/a
41	MBD4	chr3:50340137-50341188	HepG2	liver:	n/a	n/a
42	CHD2	chr3:50340382-50341265	HepG2	liver:	n/a	n/a
43	MAX	chr3:50339864-50341269	HepG2	liver:	n/a	chr3:50341173-50341183
44	CTCF	chr3:50340500-50340650	HRE	kidney:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
45	CTCF	chr3:50340520-50340670	AG09319	gingival:	n/a	chr3:50340534-50340542 chr3:50340580-50340598 chr3:50340581-50340597
46	POLR2A	chr3:50340540-50341336	H1-hESC	embryonic stem cell:	n/a	n/a
47	CEBPD	chr3:50340150-50341408	HepG2	liver:	n/a	n/a
48	RAD21	chr3:50340411-50340787	MCF-7	breast:	n/a	chr3:50340622-50340634
49	POLR2A	chr3:50339443-50341454	HepG2	liver:	n/a	n/a
50	EP300	chr3:50340059-50341146	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:50340564-50340614	HCPEpiC	choroid plexus:	n/a
2	chr3:50340564-50340614	SKMC	muscle:	n/a
3	chr3:50340564-50340614	SK-N-MC	brain:	n/a
4	chr3:50340564-50340614	MCF-7	breast:	n/a
5	chr3:50340564-50340614	BJ	skin:	n/a
6	chr3:50340564-50340614	NB4	blood:	n/a
7	chr3:50340564-50340614	U87	brain:	n/a
8	chr3:50340564-50340614	T-47D	breast:	n/a
9	chr3:50340564-50340614	GM19239	blood:	n/a
10	chr3:50340564-50340614	H1-hESC	embryonic stem cell:	embryo
11	chr3:50340564-50340614	GM12892	blood:	n/a
12	chr3:50340564-50340614	HRCEpiC	kidney:	n/a
13	chr3:50340564-50340614	Hepatocyte	liver:	n/a
14	chr3:50340564-50340614	GM12878	blood:	n/a
15	chr3:50340564-50340614	AG04450	lung:	fetal
16	chr3:50340564-50340614	Jurkat	blood:	n/a
17	chr3:50340564-50340614	HCM	heart:	n/a
18	chr3:50340564-50340614	HAEpiC	amniotic membrane:	n/a
19	chr3:50340564-50340614	NH-A	brain:	n/a
20	chr3:50340564-50340614	AoSMC	blood vessel:	n/a
21	chr3:50340564-50340614	LNCaP	prostate:	n/a
22	chr3:50340564-50340614	MCF10A-Er-Src	breast:	n/a
23	chr3:50340564-50340614	NHBE	bronchial:	n/a
24	chr3:50340564-50340614	CMK	blood:	n/a
25	chr3:50340564-50340614	IMR90	lung:	fetal
26	chr3:50340564-50340614	ECC-1	luminal epithelium:	n/a
27	chr3:50340564-50340614	HPAEpiC	pulmonary alveolar:	n/a
28	chr3:50340564-50340614	HRPEpiC	eye:	n/a
29	chr3:50340564-50340614	GM12891	blood:	n/a
30	chr3:50340564-50340614	K562	blood:	n/a
31	chr3:50340564-50340614	HMEC	breast:	n/a
32	chr3:50340564-50340614	SAEC	small airway:	n/a
33	chr3:50340564-50340614	NHDF-neo	bronchial:	n/a
34	chr3:50340564-50340614	A549	lung:	n/a
35	chr3:50340564-50340614	BE2_C	brain:	n/a
36	chr3:50340564-50340614	HepG2	liver:	n/a
37	chr3:50340564-50340614	HIPEpiC	eye:	n/a
38	chr3:50340564-50340614	AG09309	skin:	n/a
39	chr3:50340564-50340614	SK-N-SH_RA	brain:	n/a
40	chr3:50340564-50340614	Hela-S3	cervix:	n/a
41	chr3:50340564-50340614	HL-60	blood:	n/a
42	chr3:50340564-50340614	HCT-116	colon:	n/a
43	chr3:50340564-50340614	NT2-D1	testis:	n/a
44	chr3:50340564-50340614	PrEC	prostate:	n/a
45	chr3:50340564-50340614	SK-N-SH	brain:	n/a
46	chr3:50340564-50340614	ProgFib	skin:	n/a
47	chr3:50340564-50340614	ovcar-3	ovarian:	n/a
48	chr3:50340564-50340614	HRE	kidney:	n/a
49	chr3:50340564-50340614	HEK293	kidney:	embryo
50	chr3:50340564-50340614	RPTEC	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:107487055..107487690-chr3:50340350..50340874,2	Hela-S3	cervix:
2	chr3:50339705..50341283-chr3:50377540..50380265,2	K562	blood:
3	chr3:50340137..50340764-chr3:50361722..50362620,3	MCF-7	breast:
4	chr3:50340213..50340762-chr5:108745102..108745770,2	Hela-S3	cervix:
5	chr3:50327926..50342388-chr3:50350886..50359960,36	MCF-7	breast:
6	chr3:50324564..50342616-chr3:50350801..50362499,49	MCF-7	breast:
7	chr3:50334885..50342502-chr3:50352987..50366859,26	K562	blood:
8	chr3:50340483..50341210-chrX:117480073..117480951,2	Hela-S3	cervix:
9	chr12:6309543..6310399-chr3:50340422..50341257,2	Hela-S3	cervix:
10	chr3:50340330..50341202-chr9:116037757..116038408,2	Hela-S3	cervix:
11	chr3:50334334..50341950-chr3:50357130..50360296,11	K562	blood:
12	chr3:50340104..50340675-chr3:50361683..50362237,2	K562	blood:

Variant related genes	Relation type
HYAL3	TF binding region
NAT6	TF binding region
HYAL3	CpG island
NAT6	CpG island
ENSG00000114383	Chromatin interaction
ENSG00000068028	Chromatin interaction
ENSG00000198961	Chromatin interaction
ENSG00000131725	Chromatin interaction
ENSG00000257548	Chromatin interaction
ENSG00000176386	Chromatin interaction
ENSG00000068001	Chromatin interaction
ENSG00000004838	Chromatin interaction
ENSG00000136875	Chromatin interaction
ENSG00000235058	Chromatin interaction
ENSG00000008405	Chromatin interaction
ENSG00000010278	Chromatin interaction

Extended variants
information (count: 48 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:27)

rs_ID	r²[population]
rs12490837	0.94[AFR][1000 genomes]
rs2229647	0.97[AFR][1000 genomes]
rs2233476	0.91[AFR][1000 genomes]
rs2233482	0.94[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs2236946	0.83[AFR][1000 genomes]
rs35587949	0.89[AFR][1000 genomes]
rs4688679	0.91[AFR][1000 genomes]
rs4688728	0.89[AFR][1000 genomes]
rs4688736	0.97[AFR][1000 genomes]
rs58780990	1.00[AMR][1000 genomes]
rs59476380	0.86[AFR][1000 genomes]
rs59556423	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs60983897	0.93[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs61275090	1.00[AMR][1000 genomes]
rs61689858	1.00[AMR][1000 genomes]
rs61737738	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs72932956	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs72932962	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs72932983	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs72934803	1.00[AMR][1000 genomes]
rs72934806	1.00[AMR][1000 genomes]
rs72934814	1.00[AMR][1000 genomes]
rs72934815	1.00[AMR][1000 genomes]
rs72934824	1.00[AMR][1000 genomes]
rs72934827	1.00[AMR][1000 genomes]
rs72934830	1.00[AMR][1000 genomes]
rs928946	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:21 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
3	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
4	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
5	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
6	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
7	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
8	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
9	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
10	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
11	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
12	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
13	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
14	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
15	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
16	nsv590257	chr3:50302830-50393640	Genic enhancers Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
17	nsv590256	chr3:50302830-50420554	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
18	nsv876774	chr3:50302830-50436827	Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
19	nsv876773	chr3:50302830-50480131	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
20	nsv834693	chr3:50302830-50507964	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
21	nsv876775	chr3:50324672-50504896	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	82 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:94 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50337800-50353800	Weak transcription	HSMMtube	muscle
2	chr3:50338000-50340600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr3:50338000-50340600	Enhancers	Esophagus	oesophagus
4	chr3:50338000-50341600	Enhancers	Fetal Muscle Trunk	muscle
5	chr3:50338000-50342200	Weak transcription	NH-A	brain
6	chr3:50338000-50343600	Weak transcription	H9 Cell Line	embryonic stem cell
7	chr3:50338000-50352400	Weak transcription	Fetal Kidney	kidney
8	chr3:50338200-50340600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr3:50338200-50340600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
10	chr3:50338200-50340800	Weak transcription	NHLF	lung
11	chr3:50338200-50342000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr3:50338200-50343000	Weak transcription	Fetal Thymus	thymus
13	chr3:50338200-50344400	Weak transcription	Brain Germinal Matrix	brain
14	chr3:50338200-50352800	Weak transcription	Colon Smooth Muscle	Colon
15	chr3:50338200-50353800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
16	chr3:50338200-50353800	Weak transcription	Primary T helper cells PMA-I stimulated	--
17	chr3:50338200-50353800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr3:50338200-50356000	Weak transcription	Primary T cells from cord blood	blood
19	chr3:50338400-50340600	Weak transcription	Brain Substantia Nigra	brain
20	chr3:50338400-50340600	Weak transcription	HMEC	breast
21	chr3:50338400-50341400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr3:50338400-50352800	Weak transcription	Brain Anterior Caudate	brain
23	chr3:50338600-50341000	Weak transcription	Fetal Brain Female	brain
24	chr3:50338600-50342000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr3:50338600-50355600	Weak transcription	Fetal Brain Male	brain
26	chr3:50338600-50355800	Weak transcription	Brain Angular Gyrus	brain
27	chr3:50338800-50340600	Weak transcription	HUVEC	blood vessel
28	chr3:50338800-50340600	Weak transcription	NHDF-Ad	bronchial
29	chr3:50338800-50352600	Weak transcription	Monocytes-CD14+_RO01746	blood
30	chr3:50338800-50353800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
31	chr3:50338800-50354000	Weak transcription	Primary neutrophils fromperipheralblood	blood
32	chr3:50339200-50353000	Weak transcription	Primary T cells fromperipheralblood	blood
33	chr3:50339400-50340600	Flanking Active TSS	Right Ventricle	heart
34	chr3:50339400-50341400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr3:50339400-50341400	Flanking Active TSS	Hela-S3	cervix
36	chr3:50339400-50341800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr3:50339600-50340800	Flanking Active TSS	Spleen	Spleen
38	chr3:50339600-50341200	Genic enhancers	Fetal Stomach	stomach
39	chr3:50339600-50341400	Enhancers	Fetal Intestine Large	intestine
40	chr3:50339600-50341400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
41	chr3:50339800-50340600	Enhancers	Rectal Mucosa Donor 31	rectum
42	chr3:50339800-50340800	Genic enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr3:50339800-50341000	Enhancers	Sigmoid Colon	Sigmoid Colon
44	chr3:50339800-50341200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr3:50339800-50341400	Enhancers	Ovary	ovary
46	chr3:50339800-50341600	Enhancers	Fetal Muscle Leg	muscle
47	chr3:50340000-50340600	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr3:50340000-50340600	Weak transcription	Brain Inferior Temporal Lobe	brain
49	chr3:50340000-50340800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr3:50340000-50340800	Active TSS	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links